Literature DB >> 8779369

Interactions of calcium channel blockers with non-depolarising muscle relaxants in vitro.

S Sekerci1, M Tulunay.   

Abstract

The effects of two calcium channel blockers (verapamil and nicardipine) on indirectly elicited muscle twitch and possible interactions between these drugs and non-depolarising muscle relaxants (vecuronium, atracurium, pancuronium) were investigated using isolated rat phrenic nerve-hemidiaphragm preparations. Both verapamil 10(-5) M and nicardipine 10(-6) M caused significant depression of twitch amplitude. Verapamil significantly increased vecuronium- and atracurium-induced neuromuscular block, but not that produced by pancuronium. Nicardipine potentiated atracurium-induced neuromuscular block but had no effect on pancuronium- and vecuronium-induced twitch depression. Neostigmine 10(-6) M did not produce any significant changes in the maximal recovery of twitch depression induced with calcium channel blockers and muscle relaxants combinations; also, neostigmine had no effect on maximal recovery time of twitch depression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8779369     DOI: 10.1111/j.1365-2044.1996.tb07701.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  3 in total

1.  Effects of magnesium sulfate on neuromuscular function and spontaneous breathing during sevoflurane and spinal anesthesia.

Authors:  Ryohei Serita; Hiroshi Morisaki; Chikako Tanaka; Shizuko Kosugi; Shigeki Sakuraba; Junzo Takeda
Journal:  J Anesth       Date:  2007-01-30       Impact factor: 2.078

2.  Sugammadex is effective in reversing rocuronium in the presence of antibiotics.

Authors:  Mark E Hudson; Henk Rietbergen; Jacques E Chelly
Journal:  BMC Anesthesiol       Date:  2014-08-15       Impact factor: 2.217

Review 3.  [Drug interactions and the anesthesiologist].

Authors:  A S Milde; J Motsch
Journal:  Anaesthesist       Date:  2003-09       Impact factor: 1.041

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.